Presentation Information

[3T03-04]LRBA promotes drug-induced liver injury and MASLD by scaffolding MAPK activation

Daisuke Oikawa1, Yoshinori Okina1, Min Gi2, Minh Duc Pham3, Thi Thanh Thuy Le4, Yusuke Sato5, Hidetaka Kosako6, Hiroko Ikenaga3, Tsutomu Matsubara7, Hirotaka Takahashi8, Takuro Horii9, Izuho Hatada9, Tatsuya Sawasaki8, Norifumi Kawada3, Fuminori Tokunaga1,10 (1.Dept. of Med. Biochem., Grad. Sch. of Med., Osaka Metropol. Univ., 2.Dept. of Environ. Risk Aces., Grad. Sch. of Med., Osaka Metropol. Univ., 3.Dept. of Hepatol., Grad. Sch. of Med., Osaka Metropol. Univ., 4.Dept. of Glob. Edu. Med. Sci., Grad. Sch. of Med., Osaka Metropol. Univ., 5.Dept. of Chem. Biol., Grad. Sch. of Eng., Tottori Univ., 6.Inst. of Adv. Med. Sci., Tokushima Univ., 7.Dept. of Anat. Regen. Biol., Grad. Sch. of Med., Osaka Metropol. Univ., 8.PROS, Ehime. Univ., 9.Lab. of Genome Sci., Inst. for Mol. Cell. Res., Gunma Univ., 10.Res. Inst. for Drug Discov. Sci., Osaka Metropol. Univ.)
キーテクノロジー:single cell fixed RNA-seq

Keywords:

LRBA,MAPKスカフォールド,DILI,MASLD

Password required to view


Comment

To browse or post comments, you must log in.Log in